Stocktoria
Verrica Pharmaceuticals Inc. VRCA
Verrica Pharmaceuticals Inc. financials (annual)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $35.6M | $7.6M | $5.1M | $9.0M | $12.0M | — | — | — | — |
| R&D expense | $8.9M | $11.8M | $20.3M | $12.2M | $15.9M | $15.7M | $15.4M | $12.8M | $3.7M |
| SG&A expense | $35.2M | $58.8M | $47.3M | $17.4M | — | — | — | — | — |
| Operating income | -$12.2M | -$65.9M | -$65.8M | -$21.3M | -$30.9M | -$40.2M | -$30.1M | -$21.9M | -$4.5M |
| Interest expense | — | — | $4.0M | $2.2M | $4.3M | $3.0M | — | — | — |
| Income tax | $0 | $0 | $0 | $0 | — | — | — | — | — |
| Net income | -$17.9M | -$76.6M | -$67.0M | -$24.5M | -$35.1M | -$42.7M | -$28.2M | -$20.6M | -$4.5M |
| EPS (diluted) | $-1.68 | $-14.78 | $-1.48 | $-0.72 | $-1.30 | — | — | — | — |
| Operating cash flow | -$17.6M | -$60.9M | -$38.6M | -$18.6M | -$27.6M | -$30.2M | -$27.4M | -$17.9M | -$4.6M |
| Free cash flow | -$17.6M | -$61.0M | -$38.9M | -$19.0M | -$28.5M | -$31.7M | -$28.1M | -$18.6M | — |
| Cash & equivalents | $30.1M | $46.3M | $69.5M | $34.3M | $15.8M | $10.7M | $9.2M | $10.3M | $8.7M |
| Inventory | $2.2M | $2.5M | $1.0M | $0 | — | — | — | — | — |
| Total assets | $47.1M | $54.1M | $81.6M | $44.7M | $80.1M | $74.2M | $68.4M | $91.9M | $9.1M |
| Total liabilities | $22.4M | $64.0M | $61.8M | $4.7M | $47.5M | $41.2M | $3.4M | $2.5M | $616,000 |
| Shareholders' equity | $24.7M | -$9.9M | $19.8M | $40.0M | $32.6M | $33.0M | $65.0M | $89.4M | -$7.0M |
Growth · year-over-year · Revenue CAGR 31.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +370.2% | +47.7% | -43.3% | -24.7% | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.